Inflammation mediated angiogenesis in chronic lymphocytic leukemia Olivera Mitrović-AjtićEmilija ŽivkovićVladan P. Čokić Original Article 07 May 2024
Risk factors and survival outcomes in children with early cardiotoxicity after allogeneic hematopoietic stem cell transplantation Ke TongYan MengYing Dou Research 06 May 2024
Latent tuberculosis infection detected by quantiferon-TB assay in patients with multiple myeloma receiving novel drugs: focus on reactivation prophylaxis in a retrospective, single-center study Nicola SgherzaPaola CurciPellegrino Musto Correspondence 04 May 2024
Economic evaluation of anti-CD19 CAR T-cell pathway for large B-cell lymphomas in the real-life setting: the experience of an Italian hub center in the first three years of activity Rossana Di StasoBeatrice CasadeiLisa Argnani Research Open access 02 May 2024
Combining serum microRNAs and machine learning algorithms for diagnosing infectious fever after HSCT Wenwei ShaoYixuan WangXiaolei Pei Research 01 May 2024 Pages: 2089 - 2102
Sirolimus is effective for refractory/relapsed idiopathic multicentric Castleman disease: A single-center, retrospective study Yan-ting LiuYu-han GaoLu Zhang Research 01 May 2024
Impact of the presence and number of chromosomal abnormalities on the clinical outcome in Waldenström Macroglobulinemia: a monocentric experience NicolĂ² DanesinLaura BonaldiFrancesco Piazza Research Open access 30 April 2024
Advances in hematopoietic stem cells ex vivo expansion associated with bone marrow niche Ju DengYanhong TanHongwei Wang Review Article 30 April 2024
Early predictor for differentiation syndrome in newly diagnosed acute promyelocytic leukaemia patients treated with single-agent arsenic trioxide Yujuan GaoYuanyuan XiYanhua Su Review 29 April 2024
Tixagevimab/cilgavimab (AZD7442/Evusheld) prevent from COVID19 in patients with hematologic malignancies under active chemotherapy Yoo Jin LeeHyun-Ki KimJae-Cheol Jo Research 28 April 2024
GLI1 polymorphisms influence remission rate and prognosis of young de novo acute myeloid leukemia patients treated with cytarabine-based chemotherapy Yanfeng LiuYi LiuXiaoping Chen Research 27 April 2024 Pages: 1967 - 1977
Myeloid sarcoma with RAM phenotype in an adult male presenting with CNS relapse; no longer a pediatric disease Devasis PandaNarender TejwaniDinesh Bhurani Case Report 27 April 2024
Analysis of mutation profiles in extranodal NK/T-cell lymphoma: clinical and prognostic correlations Yu-Cheng ChangHui-Jen TsaiSung-Hsin Kuo Original Article 27 April 2024
Long-term health-related quality of life and mental health in patients with immune thrombotic thrombocytopenic purpura Olga MulasFabio EfficaceGiovanni Caocci Research Open access 27 April 2024
Systemic inflammatory autoimmune disease before allogeneic hematopoietic stem cell transplantation is a risk factor for death in patients with myelodysplastic syndrome or chronic myelomonocytic leukemia Kumiyo TazoeNaonori HaradaHirohisa Nakamae Original Article 25 April 2024 Pages: 2059 - 2072
Enhancing end-of-life care: ethical considerations and the role of social work in geriatric bone marrow biopsy decisions Shijie GuoGuang Yang Correspondence 25 April 2024
Hematocrit control and thrombotic risk in patients with polycythemia vera treated with ruxolitinib in clinical practice Aleksander ChojeckiDanielle BoselliMichael Richard Grunwald Research Open access 25 April 2024
Daratumumab and venetoclax combined with CAGE for late R/R T-ALL/LBL patients: Single-arm, open-label, phase I study Hui ShiFan YangKai Hu Research 25 April 2024
Dermatologic manifestations of hematologic disorders Hannah L. KingGenevieve B. BenedettiKylee L. Martens Review 25 April 2024
Unrelated umbilical cord blood transplantation with low-dose anti-thymocyte globulin for children with severe aplastic anemia: A case series Mengze HuJunhui LiLitian Xuan Research 24 April 2024 Pages: 2103 - 2111
Cytogenetic and epidemiological profile of chronic myeloid leukemia in Morocco Sara BenchikhSoro Somda Georgina CharlèneSanaa Nassereddine Original Article 24 April 2024
Letter to Editor: Treatment with the apoptosis inhibitor asunercept reduces clone sizes in patients with lower risk myelodysplastic neoplasms Syeda Dua e Zehra ZaidiSyeda Mahrukh Fatima ZaidiBurhanuddin Sohail Rangwala Correspondence 23 April 2024 Pages: 2163 - 2164
Triple a score (AAA: age, absolute neutrophil count and absolute lymphocyte count) and its prognostic utility in patients with overt fibrotic and prefibrotic myelofibrosis Marko LucijanicIvan KrecakRajko Kusec Correspondence 23 April 2024 Pages: 2157 - 2159
Association of JAK2V617F allele burden and clinical correlates in polycythemia vera: a systematic review and meta-analysis Chih-Cheng ChenJustin L. ChenHsin-An Hou Research Open access 23 April 2024 Pages: 1947 - 1965
SARS-CoV-2 infection-induced immune thrombocytopenia: a systematic review of current reports Ryohei OnoIzumi Kitagawa Review 23 April 2024
Bortezomib elevates intracellular free Fe2+ by enhancing NCOA4-mediated ferritinophagy and synergizes with RSL-3 to inhibit multiple myeloma cells Yanyan ZhangFen HeJiliang Xia Research 22 April 2024
Mendelian randomization of circulating proteome identifies IFN-γ as a druggable target in aplastic anemia Shanshan QinYingxin JiangYunfeng Cheng Original Article 22 April 2024
Multi-center study of COVID-19 infection in elderly patients with lymphoma: on behalf of Jiangsu Cooperative Lymphoma Group (JCLG) Huayuan ZhuXiao LuWenyu Shi Research 22 April 2024
Expert consensus on the management of infusion-related reactions (IRRs) in patients with sickle cell disease (SCD) receiving crizanlizumab: a RAND/UCLA modified Delphi panel Julie KanterKenneth I. AtagaMichael S. Broder Original Article 20 April 2024 Pages: 1909 - 1917
Diagnosing aceruloplasminemia: navigating through red herrings Zeni KharelHimal KharelPradyumna D. Phatak Case Report 19 April 2024 Pages: 2173 - 2176
Psychological and physical side effects during G-CSF mobilization in related donors of allo-HCT Lingxia CaiDiange JinYishan Ye Research 19 April 2024
Pharmacogenetic guided versus standard warfarin dosing for routine clinical care with its pharmacoeconomic impact: a randomized controlled clinical trial Aishwarya AnandNaveen C HegdeSamir Malhotra Research 18 April 2024 Pages: 2133 - 2144
Incidence of pleural effusion with dasatinib and the effect of switching therapy to a different TKI in patients with chronic phase CML Akriti G JainQuinto GesiottoKendra Sweet Research Open access 18 April 2024 Pages: 1941 - 1945
COVID-19 severity in patients with chronic lymphocytic leukemia treated with venetoclax: a single-center observational cohort study Sophie ThauChristian Bjørn PoulsenLars Møller Pedersen Research Open access 18 April 2024
Immune reconstitution after single-unit umbilical cord blood transplantation using anti-thymoglobulin and myeloablative conditioning in adults with hematological malignancies Lourdes CordĂ³nPedro ChorĂ£oJaime Sanz Research 18 April 2024
Inhibition of NRF2 signaling overcomes acquired resistance to arsenic trioxide in FLT3-mutated Acute Myeloid Leukemia Daniel Zechariah Paul JebanesanRaveen Stephen Stallon IllangeswaranPoonkuzhali Balasubramanian Original Article 17 April 2024 Pages: 1919 - 1929
Dry gangrene in a patient with sickle cell disease on hydroxyurea: a case report Gurjeet BhanguKelsey UminskiNatalia Rydz Letter to the Editor 17 April 2024
Monocyte-to-platelets ratio (MPR) at diagnosis is associated with inferior progression-free survival in patients with mantle cell lymphoma: a multi-center real-life survey Andrea DuminucoAlessandra RomanoCarlo Visco Research 17 April 2024
Thromboprophylaxis in multiple myeloma: a case-based review with practical guidelines Charalampos CharalampousDarshi ShahRajshekhar Chakraborty Review 17 April 2024
A new score for predicting intracranial hemorrhage in patients using antiplatelet drugs Fuxin MaZhiwei ZengJinhua Zhang Research 17 April 2024
Comparison of human leukocyte antigen in patients with paroxysmal nocturnal hemoglobinuria of different clone sizes Zhuxin ZhangQinglin HuBing Han Original Article 15 April 2024 Pages: 1897 - 1907
Cerebral infarction in a patient with inhibitor-positive hemophilia B treated with plasma-derived factor VIIa and factor X mixture Katsuyoshi ShimozawaHiroshi YagasakiIchiro Morioka Correspondence 13 April 2024 Pages: 2161 - 2162
Therapeutic progress in relapsed/refractory multiple myeloma Qi ChenMin ZhangYamin Tan Review Article 13 April 2024 Pages: 1833 - 1841
Post-transplant lymphoproliferative disease of two different histological types Takashi OnakaKoichi OhshimaAkihito Yonezawa Dear Editor, 13 April 2024
Impact of minimal residual disease response and of status of disease on survival after blinatumomab in B-cell acute lymphoblastic leukemia: results from a real-life study Salvatore LeottaUros MarkovicGiuseppe Milone Research 13 April 2024
Loss of NLRP6 expression increases the severity of intestinal injury after syngeneic hematopoietic stem cell transplantation Shengyun ZhuXue ZhangKailin Xu Research 12 April 2024
Upfront allogeneic hematopoietic stem cell transplantation for adult T-cell acute lymphoblastic leukemia/lymphoma in first complete remission: a single-center study Zhenyang GuFei LiDaihong Liu Original Article 12 April 2024
Comparable outcomes of allogeneic peripheral blood versus bone marrow hematopoietic stem cell transplantation from a sibling donor for pediatric patients Bo Kyung KimKyung Taek HongHyoung Jin Kang Original Article Open access 10 April 2024 Pages: 2051 - 2058
Could it be VEXAS? Hippolyte GuerineauMilena KohnAurélie Cabannes-Hamy Case Report 09 April 2024 Pages: 2169 - 2171
Bibliometric analysis of worldwide research on Polycythemia Vera in the 21st century Zhengjiu CuiFei LuoYueli Pan Review 09 April 2024
